Management in patients with Helicobacter pylori eradication failure;Postçpowanie w przypadku nieskutecznego leczenia eradykacyjnego Helicobacter pylori

Advances in Clinical and Experimental Medicine

Volumn 15, Issue 6, 2006, Pages 1087-1092

  Annabhani, Abdulhabib ^a   Paradowski, Leszek ^a   Sajewicz, Zbigniew ^a   Ewa, Waszczuk ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Eradication; Helicobacter pylori; Treatment regimens

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CLARITHROMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; RIFABUTIN; TETRACYCLINE; TINIDAZOLE;

HEALTH CARE FACILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATIENT CARE; PATIENT REFERRAL; REVIEW; STOMACH ULCER; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT PLANNING;

HELICOBACTER PYLORI;

EID: 33846695464     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Maltfertheiner P, Leodolter A, Peitz U: Cure of Helicobacter pylori-associated ulcer disease through eradication. Baillière's Clin Gastroenterol 2000, 14, 119-132.
2. Gabryelewicz A, Czajkowski A, Skrodzka D et al: Wieloośrodkowe badania skuteczności i bezpieczeństwa leczenia lanzoprazolem, klarytromycyna i amoksycylina wrzodu dwunastnicy u pacjentów z infekcja Helicobacter pylori. Gastoenterol Pol 1999, 6, 349-353.
3. Gil M: Rola Helicobacterpylori w patogenezie chłoniaka MALT w żoładka. Gastroenterol Pol 1997, 4, 75-78.
4. Boer WA, Tytgat GNJ: Treatment of Helicobacter pylori infection, BMJ 2000, 320, 31-34.
5. Gisbert JP, Pajares JM: Helicobacter pylori rescue regimen when proton pump inhibitor- based triple therapies fail. Aliment Pharmacol Ther 2002, 16, 1047-1057.
6. Broer WA, Borody TJ: Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy. Dig Liver Dis 2000, 32, 673-675.
7. Midolo PD, Lambert JR, Turmidge J: Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996, 11, 290-292.
8. Ducons JA, Santolaria S, Guirao R et al: Impact of clarithromycin resistance on effectiveness of regimen for Helicobacter pylori: a prospective study of 1-week lansopazole, amoxicillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther 1999, 13, 775-780.
9. Graham DY, Lew GM, Malaty HM et al: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992, 102, 493-496.
10. Matsuo K, Hamajima N, Ikehara Y et al: Smoking and polymorphisms of fucosyltransferase gene Le affect success of Helicobacter pylori infection eradication with lansoprazole, amoxicillin and clarithromycin. Epidemiol Infect 2003, 130, 227-233.
11. Namiot Z, Namiot DB, Kemona A et al: The effect of cigarette smoking and alcohol consumption on efficacy of Helicobacter pylori eradication. Pol Arch Med Wewn 2000, 104, 369-374.
12. Sapone A, Vaira D, Trespidi S et al: The clinical role of cytochrome p450 genotypes in Helicobacter pylori management. Am J Gastroenterol 2003, 98, 110-1015.
13. Annabhani A: Zakażenie Helicobacter pylori u osób czesto leczonych antybiotykami i chemioterapeutykami. Rozprawa doktorska, AM Wrocław 2002.
14. Grupa Robocza Polskiego Towarzystwa Gastroenterologii: Postepowanie w zakażeniu Helicobacter pylori. Gastroenterol Pol 2004, 11, 41-48.
15. Parente F, Cucino C, Porro GB: Treatment options for patients with Helicobacter infection resistant to one or more eradication attempts. Dig Liver Dis 2003, 35, 523-528.
16. European Helicobacter Pylori Study Group: Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus. Gut 1997, 41, 276.
17. Łekowska-Kochaniak A, Popowski J: Lekoopornogść szczepów Helicobacter pylori izolowanych od pacjentów. Gastroenterol Pol 1999, 6, 209-213.
18. Gościniak B, Iwańczak B, Przondo-Mordalska A et al: Ocena wrażliwości szczepów Helicobacter pylori na wybrane chemioterapeutyki. Pediat Pol 2001, 76, 873-877.
19. Dzierzanowska-Fangrat K, Rozynek E, Celińska-Cedro D et al: Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study. Int J Antimicrob Agents 2005, 26, 230-234.
20. Nagahara A, Miwa H, Ohkura R et al: Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection. J Gastoenterol Hepatol 2001, 16, 613-618.
21. Avidan B, Mezler E, Keller N et al: The effect of culture result for Helicobacter pylori on the choice of treatment following failure of initial eradication. Isr Med Assoc J 2001, 3, 163-165.
22. Gisbert JP, Calvet X, Bujanda I et al: Rescue therapy with rifabutin after multiple Helicobacter pylori treatment failures. Helicobacter 2003, 8, 90-94.
23. Gasbarrini A, Ojetti V, Armuzzi A et al: Efficacy of a multistep strategy for Helicobacter eradication. Aliment Pharmacol Ther 2000, 14, 79-83.
24. Beales IL: Efficacy of Helicobacter pylori eradication therapies. A single centre observational study. BMC Gastroenterol 2001, 1, 7-16.
25. Kawabata H, Habu Y, Tomioka H et al: Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regiment of proton pump inhibitor, amoxicillin and clarithromycin. Aliment Pharmacol Ther 2003, 17, 259-264.
26. Zullo A, Hassan C, De Fancesco V et al: A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig Liver Dis 2003, 35, 232-236.
27. Isakov V, Domareva I, Koudryavtseva L et al: Furazolidone-based triple rescue therapy vs quadruple rescue therapy for the eradication of Helicobacter resistant to metronidazole. Aliment Pharmacol Ther 2002, 16, 1277-1282.
28. Zullo A, Vaira D, Vakil N et al: High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003, 17, 719.
29. Perri F, Qasimt A, Marras L et al: Treatment of Helicobacter pylori infection. Helicobacter pylori 2003, 8, 53-60.
30. Płaneta. Malecka I, Bak-Romaniszyn L, Plewińska EM et al: Rola probiotyków w leczeniu Helicobacter pylori - doniesienie wstepne. Gastroenterol Pol 2004, 11, 219-222.